Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference
- None.
- None.
The public may access a live webcast of the fireside chat atHaemonetics' Investor Relations website or at the following link:
A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit .
Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury
(781) 356-9763
[email protected]
David Trenk, Manager-Investor Relations
(203) 733-4987
[email protected]
Media Contact:
Josh Gitelson, Sr. Director-Global Communications
(781) 356-9776
[email protected]
View original content to download multimedia:
SOURCE Haemonetics Corporation